Anti-Human CD3E & EpCAM Recombinant Antibody(Catumaxomab)
-
产品编号
YR1139
-
别名
科研级 Catumaxomab ( 卡妥索单抗 ), Anti-CD3E & EpCAM Recombinant Antibody, Research Grade Catumaxomab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Catumaxomab ( 卡妥索单抗 ), Anti-CD3E & EpCAM Recombinant Antibody, Research Grade Catumaxomab |
| Catalog Number | YR1139 |
| Molecular Name | Catumaxomab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG2a Kappa/G2b Lambda |
| Formulation | PBS, pH7.5 |
| Background | Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in people with metastasizing cancer. It binds to antigens CD3 and EpCAM. It was developed by Fresenius Biotech and Trion Pharma (Germany). |
| CAS Number | 509077-98-9 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Molecular Weight | 150.51 kDa |
| Target | CD3E & EpCAM[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
